Year |
Citation |
Score |
2020 |
Simpson SM, Widanapathirana L, Su JT, Sung S, Watrous D, Qiu J, Pearson E, Evanoff A, Karunakaran D, Chacon JE, Kiser PF. Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate. Pharmaceutical Research. 37: 83. PMID 32296951 DOI: 10.1007/S11095-020-2777-2 |
0.367 |
|
2018 |
Calder BJ, Schieffer RJ, Bryndza Tfaily E, D'Aquila RT, Greene G, Carballo-Diéguez A, Giguere R, Kiser PF, Hope TJ. Qualitative Consumer Research on Acceptance of Long-acting PrEP Products among MSM and Medical Practitioners in the United States. Aids Research and Human Retroviruses. PMID 30229684 DOI: 10.1089/Aid.2018.0214 |
0.341 |
|
2018 |
Thurman AR, Schwartz JL, Brache V, Clark MR, McCormick T, Chandra N, Marzinke MA, Stanczyk FZ, Dezzutti CS, Hillier SL, Herold BC, Fichorova R, Asin SN, Rollenhagen C, Weiner D, ... Kiser P, et al. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women. Plos One. 13: e0199778. PMID 29953547 DOI: 10.1371/Journal.Pone.0199778 |
0.369 |
|
2017 |
Su JT, Teller RS, Srinivasan P, Zhang J, Martin A, Sung S, Smith JM, Kiser PF. A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates. Pharmaceutical Research. PMID 28770490 DOI: 10.1007/S11095-017-2224-1 |
0.35 |
|
2017 |
Srinivasan P, Zhang J, Dinh CT, Teller RS, McNicholl JM, Kiser PF, Herold BC, Smith JM. Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings. Journal of Medical Primatology. 46: 129-136. PMID 28748662 DOI: 10.1111/Jmp.12299 |
0.369 |
|
2016 |
Greene GJ, Swann G, Fought AJ, Carballo-Diéguez A, Hope TJ, Kiser PF, Mustanski B, D'Aquila RT. Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men. Aids and Behavior. PMID 27770215 DOI: 10.1007/S10461-016-1565-9 |
0.353 |
|
2016 |
Carias AM, Allen SA, Fought AJ, Kotnik Halavaty K, Anderson MR, Jimenez ML, McRaven MD, Gioia CJ, Henning TR, Kersh EN, Smith JM, Pereira LE, Butler K, McNicholl SJ, Hendry RM, ... Kiser PF, et al. Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract. Plos Pathogens. 12: e1005885. PMID 27658293 DOI: 10.1371/Journal.Ppat.1005885 |
0.336 |
|
2016 |
Gunn BM, Schneider JR, Shansab M, Bastian AR, Fahrbach KM, Smith AD, Mahan AE, Karim MM, Licht AF, Zvonar I, Tedesco J, Anderson MR, Chapel A, Suscovich TJ, Malaspina DC, ... ... Kiser PF, et al. Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16. Mucosal Immunology. PMID 26960182 DOI: 10.1038/Mi.2016.8 |
0.351 |
|
2016 |
Guthrie KM, Dunsiger S, Vargas S, Fava JL, Shaw JG, Rosen RK, Kiser PF, Kojic EM, Friend DR, Katz D. Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design. Aids Research and Human Retroviruses. PMID 26942455 DOI: 10.1089/Aid.2015.0275 |
0.305 |
|
2015 |
Teller RS, Malaspina DC, Rastogi R, Clark JT, Szleifer I, Kiser PF. Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral release. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26723526 DOI: 10.1016/J.Jconrel.2015.12.035 |
0.362 |
|
2015 |
Taneva E, Crooker K, Park SH, Su JT, Ott A, Cheshenko N, Szleifer I, Kiser PF, Frank B, Mesquita PM, Herold BC. Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Pre-exposure Prophylaxis. Antimicrobial Agents and Chemotherapy. PMID 26711762 DOI: 10.1128/Aac.02793-15 |
0.349 |
|
2015 |
Morrow Guthrie K, Vargas S, Shaw JG, Rosen RK, van den Berg JJ, Kiser PF, Buckheit K, Bregman D, Thompson L, Jensen K, Johnson T, Buckheit RW. The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development. Plos One. 10: e0145642. PMID 26695431 DOI: 10.1371/Journal.Pone.0145642 |
0.33 |
|
2015 |
Keller MJ, Mesquita PM, Marzinke MA, Teller R, Espinoza L, Atrio JM, Lo Y, Frank B, Srinivasan S, Fredricks DN, Rabe L, Anderson PL, Hendrix CW, Kiser PF, Herold BC. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring. Aids (London, England). PMID 26605514 DOI: 10.1097/Qad.0000000000000979 |
0.379 |
|
2015 |
Rastogi R, Su J, Mahalingam A, Clark J, Sung S, Hope T, Kiser PF. Engineering and Characterization of Simplified Vaginal and Seminal Fluid Simulants. Contraception. PMID 26585883 DOI: 10.1016/J.Contraception.2015.11.008 |
0.556 |
|
2015 |
Seay K, Khajoueinejad N, Zheng JH, Kiser P, Ochsenbauer C, Kappes JC, Herold B, Goldstein H. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment. Journal of Virology. 89: 9559-70. PMID 26157126 DOI: 10.1128/Jvi.01326-15 |
0.362 |
|
2015 |
Ugaonkar SR, Clark JT, English LB, Johnson TJ, Buckheit KW, Bahde RJ, Appella DH, Buckheit RW, Kiser PF. An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission. Journal of Pharmaceutical Sciences. 104: 3426-39. PMID 26149293 DOI: 10.1002/Jps.24551 |
0.447 |
|
2015 |
Smith JM, Srinivasan P, Teller RS, Lo Y, Dinh CT, Kiser PF, Herold BC. Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 1-5. PMID 25321184 DOI: 10.1097/Qai.0000000000000402 |
0.325 |
|
2014 |
Srinivasan P, Dinh C, Zhang J, Pau CP, McNicholl JM, Lo Y, Herold BC, Teller R, Kiser P, Smith JM. Pharmacokinetic evaluation of tenofovir disoproxil fumarate released from an intravaginal ring in pigtailed macaques after 6 months of continuous use. Journal of Medical Primatology. 43: 364-9. PMID 25379594 DOI: 10.1111/Jmp.12119 |
0.308 |
|
2014 |
Clark JT, Clark MR, Shelke NB, Johnson TJ, Smith EM, Andreasen AK, Nebeker JS, Fabian J, Friend DR, Kiser PF. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy. Plos One. 9: e88509. PMID 24599325 DOI: 10.1371/Journal.Pone.0088509 |
0.427 |
|
2014 |
Nixon B, Jandl T, Teller RS, Taneva E, Wang Y, Nagaraja U, Kiser PF, Herold BC. Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety. Antimicrobial Agents and Chemotherapy. 58: 1153-60. PMID 24323471 DOI: 10.1128/Aac.01818-13 |
0.324 |
|
2014 |
van den Berg JJ, Rosen RK, Bregman DE, Thompson LA, Jensen KM, Kiser PF, Katz DF, Buckheit K, Buckheit RW, Morrow KM. "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels. Aids and Behavior. 18: 862-70. PMID 24248674 DOI: 10.1007/S10461-013-0652-4 |
0.361 |
|
2013 |
Friend DR, Clark JT, Kiser PF, Clark MR. Multipurpose prevention technologies: products in development. Antiviral Research. 100: S39-47. PMID 24188708 DOI: 10.1016/J.Antiviral.2013.09.030 |
0.393 |
|
2013 |
Mesquita PM, Srinivasan P, Johnson TJ, Rastogi R, Evans-Strickfaden T, Kay MS, Buckheit KW, Buckheit RW, Smith JM, Kiser PF, Herold BC. Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties. Retrovirology. 10: 113. PMID 24156604 DOI: 10.1186/1742-4690-10-113 |
0.387 |
|
2013 |
Smith JM, Rastogi R, Teller RS, Srinivasan P, Mesquita PM, Nagaraja U, McNicholl JM, Hendry RM, Dinh CT, Martin A, Herold BC, Kiser PF. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Proceedings of the National Academy of Sciences of the United States of America. 110: 16145-50. PMID 24043812 DOI: 10.1073/Pnas.1311355110 |
0.437 |
|
2013 |
Rastogi R, Teller RS, Mesquita PM, Herold BC, Kiser PF. Osmotic pump tablets for delivery of antiretrovirals to the vaginal mucosa. Antiviral Research. 100: 255-8. PMID 23973812 DOI: 10.1016/J.Antiviral.2013.08.007 |
0.412 |
|
2013 |
Friend DR, Kiser PF. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antiviral Research. 99: 391-400. PMID 23845918 DOI: 10.1016/J.Antiviral.2013.06.021 |
0.383 |
|
2013 |
Shukair SA, Allen SA, Cianci GC, Stieh DJ, Anderson MR, Baig SM, Gioia CJ, Spongberg EJ, Kauffman SM, McRaven MD, Lakougna HY, Hammond C, Kiser PF, Hope TJ. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunology. 6: 427-34. PMID 22990624 DOI: 10.1038/Mi.2012.87 |
0.38 |
|
2012 |
Johnson TJ, Clark MR, Albright TH, Nebeker JS, Tuitupou AL, Clark JT, Fabian J, McCabe RT, Chandra N, Doncel GF, Friend DR, Kiser PF. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Antimicrobial Agents and Chemotherapy. 56: 6272-83. PMID 23006751 DOI: 10.1128/Aac.01431-12 |
0.411 |
|
2012 |
Clark JT, Johnson TJ, Clark MR, Nebeker JS, Fabian J, Tuitupou AL, Ponnapalli S, Smith EM, Friend DR, Kiser PF. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 240-8. PMID 22981701 DOI: 10.1016/J.Jconrel.2012.08.033 |
0.422 |
|
2012 |
Kiser PF, Mesquita PM, Herold BC. A perspective on progress and gaps in HIV prevention science. Aids Research and Human Retroviruses. 28: 1373-8. PMID 22966871 DOI: 10.1089/Aid.2012.0277 |
0.376 |
|
2012 |
Mesquita PM, Rastogi R, Segarra TJ, Teller RS, Torres NM, Huber AM, Kiser PF, Herold BC. Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. The Journal of Antimicrobial Chemotherapy. 67: 1730-8. PMID 22467632 DOI: 10.1093/Jac/Dks097 |
0.414 |
|
2012 |
Kiser PF, Mahalingam A, Fabian J, Smith E, Damian FR, Peters JJ, Katz DF, Elgendy H, Clark MR, Friend DR. Design of tenofovir-UC781 combination microbicide vaginal gels. Journal of Pharmaceutical Sciences. 101: 1852-64. PMID 22359356 DOI: 10.1002/Jps.23089 |
0.619 |
|
2012 |
Kiser PF, Johnson TJ, Clark JT. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. Aids Reviews. 14: 62-77. PMID 22297505 |
0.301 |
|
2012 |
Ham AS, Ugaonkar SR, Shi L, Buckheit KW, Lakougna H, Nagaraja U, Gwozdz G, Goldman L, Kiser PF, Buckheit RW. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection. Journal of Pharmaceutical Sciences. 101: 1423-35. PMID 22227864 DOI: 10.1002/Jps.23026 |
0.438 |
|
2012 |
Johnson TJ, Srinivasan P, Albright TH, Watson-Buckheit K, Rabe L, Martin A, Pau CP, Hendry RM, Otten R, McNicholl J, Buckheit R, Smith J, Kiser PF. Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings. Antimicrobial Agents and Chemotherapy. 56: 1291-9. PMID 22155820 DOI: 10.1128/Aac.05721-11 |
0.451 |
|
2012 |
Clark MR, Johnson TJ, McCabe RT, Clark JT, Tuitupou A, Elgendy H, Friend DR, Kiser PF. A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781. Journal of Pharmaceutical Sciences. 101: 576-87. PMID 21976110 DOI: 10.1002/Jps.22781 |
0.434 |
|
2012 |
Clark J, Johnson T, Shelke N, Clark M, Doncel G, Friend D, Kiser P. A 90-day intravaginal ring for prevention of HIV acquisition and unplanned pregnancy Contraception. 86: 176. DOI: 10.1016/J.Contraception.2012.04.026 |
0.345 |
|
2011 |
Clark MR, Kiser PF, Loxley A, McConville C, Malcolm RK, Friend DR. Pharmacokinetics of UC781-loaded intravaginal ring segments in rabbits: a comparison of polymer matrices. Drug Delivery and Translational Research. 1: 238-46. PMID 25788242 DOI: 10.1007/S13346-011-0032-4 |
0.4 |
|
2011 |
Kaur M, Gupta KM, Poursaid AE, Karra P, Mahalingam A, Aliyar HA, Kiser PF. Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine. Drug Delivery and Translational Research. 1: 223-37. PMID 25788241 DOI: 10.1007/S13346-011-0027-1 |
0.636 |
|
2011 |
Mahalingam A, Geonnotti AR, Balzarini J, Kiser PF. Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry. Molecular Pharmaceutics. 8: 2465-75. PMID 21879735 DOI: 10.1021/Mp2002957 |
0.644 |
|
2011 |
Mahalingam A, Jay JI, Langheinrich K, Shukair S, McRaven MD, Rohan LC, Herold BC, Hope TJ, Kiser PF. Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system. Biomaterials. 32: 8343-55. PMID 21875751 DOI: 10.1016/J.Biomaterials.2011.05.001 |
0.654 |
|
2011 |
Clark MR, Aliyar HA, Lee CW, Jay JI, Gupta KM, Watson KM, Stewart RJ, Buckheit RW, Kiser PF. Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles. International Journal of Pharmaceutics. 413: 10-18. PMID 21511017 DOI: 10.1016/J.Ijpharm.2011.04.004 |
0.41 |
|
2011 |
Mahalingam A, Simmons AP, Ugaonkar SR, Watson KM, Dezzutti CS, Rohan LC, Buckheit RW, Kiser PF. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Antimicrobial Agents and Chemotherapy. 55: 1650-60. PMID 21245437 DOI: 10.1128/Aac.01368-10 |
0.657 |
|
2011 |
Jay JI, Langheinrich K, Hanson MC, Mahalingam A, Kiser PF. Unequal stoichiometry between crosslinking moieties affects the properties of transient networks formed by dynamic covalent crosslinks Soft Matter. 7: 5826-5835. DOI: 10.1039/C1Sm05209H |
0.593 |
|
2010 |
Malcolm RK, Edwards KL, Kiser P, Romano J, Smith TJ. Advances in microbicide vaginal rings. Antiviral Research. 88: S30-9. PMID 21109066 DOI: 10.1016/J.Antiviral.2010.09.003 |
0.372 |
|
2010 |
Mahalingam A, Smith E, Fabian J, Damian FR, Peters JJ, Clark MR, Friend DR, Katz DF, Kiser PF. Design of a semisolid vaginal microbicide gel by relating composition to properties and performance. Pharmaceutical Research. 27: 2478-91. PMID 20842411 DOI: 10.1007/S11095-010-0244-1 |
0.594 |
|
2010 |
Jay JI, Lai BE, Myszka DG, Mahalingam A, Langheinrich K, Katz DF, Kiser PF. Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors. Molecular Pharmaceutics. 7: 116-29. PMID 20014858 DOI: 10.1021/Mp900159N |
0.647 |
|
2010 |
Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 39: 203-12. PMID 19958831 DOI: 10.1016/J.Ejps.2009.11.007 |
0.392 |
|
2010 |
Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF. Corrigendum to "Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir" [Eur. J. Pharm. Sci. 39 (2010) 203-212] European Journal of Pharmaceutical Sciences. 41: 736. DOI: 10.1016/J.Ejps.2010.09.010 |
0.305 |
|
2009 |
Jay JI, Shukair S, Langheinrich K, Hanson MC, Cianci GC, Johnson TJ, Clark MR, Hope TJ, Kiser PF. Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel. Advanced Functional Materials. 19: 2969-2977. PMID 23101003 DOI: 10.1002/Adfm.200900757 |
0.396 |
|
2009 |
Johnson T, Gupta K, Kiser P. Design of Intravaginal Ring for Simultaneous Delivery of Antiretroviral Drugs Antiviral Research. 82: A74. DOI: 10.1016/J.Antiviral.2009.02.194 |
0.33 |
|
2009 |
Jay J, Lai B, Kiser P. Multivalent Synthetic Lectin Polymers Against HIV Antiviral Research. 82: A63-A64. DOI: 10.1016/J.Antiviral.2009.02.153 |
0.403 |
|
2009 |
Clark M, Kiser P. In situ crosslinked hydrogels formed using Cu(I)-free Huisgen cycloaddition reaction Polymer International. 58: 1190-1195. DOI: 10.1002/Pi.2650 |
0.333 |
|
2009 |
Gupta KM, Pearce SM, Poursaid AE, Aliyar HA, Tresco PA, Mitchnik MA, Kiser PF. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1 (Journal of Pharmaceutical Sciences (2008) 97, (4228-4239)) Journal of Pharmaceutical Sciences. 98: 1199. DOI: 10.1002/Jps.21700 |
0.385 |
|
2008 |
Roberts MC, Mahalingam A, Hanson MC, Kiser PF. Chemorheology of phenylboronate-salicylhydroxamate crosslinked hydrogel networks with a sulfonated polymer backbone. Macromolecules. 41: 8832-8840. PMID 23132956 DOI: 10.1021/Ma8012674 |
0.616 |
|
2008 |
Gupta KM, Pearce SM, Poursaid AE, Aliyar HA, Tresco PA, Mitchnik MA, Kiser PF. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. Journal of Pharmaceutical Sciences. 97: 4228-39. PMID 18338805 DOI: 10.1002/Jps.21331 |
0.451 |
|
2007 |
Gupta KM, Barnes SR, Tangaro RA, Roberts MC, Owen DH, Katz DF, Kiser PF. Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles. Journal of Pharmaceutical Sciences. 96: 670-81. PMID 17154368 DOI: 10.1002/Jps.20752 |
0.448 |
|
2005 |
Eichenbaum KD, Thomas AA, Eichenbaum GM, Gibney BR, Needham D, Kiser PF. Oligo-α-hydroxy ester cross-linkers: Impact of cross-linker structure on biodegradable hydrogel networks Macromolecules. 38: 10757-10762. DOI: 10.1021/Ma0518306 |
0.315 |
|
2005 |
Thomas AA, Kim IT, Kiser PF. Symmetrical biodegradable crosslinkers for use in polymeric devices Tetrahedron Letters. 46: 8921-8925. DOI: 10.1016/J.Tetlet.2005.10.066 |
0.392 |
|
2000 |
Kiser PF, Wilson G, Needham D. Lipid-coated microgels for the triggered release of doxorubicin. Journal of Controlled Release : Official Journal of the Controlled Release Society. 68: 9-22. PMID 10884575 DOI: 10.1016/S0168-3659(00)00236-4 |
0.346 |
|
1999 |
Eichenbaum GM, Kiser PF, Shah D, Simon SA, Needham D. Investigation of the swelling response and drug loading of ionic microgels: The dependence on functional group composition Macromolecules. 32: 8996-9006. DOI: 10.1021/Ma9908393 |
0.32 |
|
1999 |
Eichenbaum GM, Kiser PF, Dobrynin AV, Simon SA, Needham D. Investigation of the swelling response and loading of ionic microgels with drugs and proteins: the dependence on cross-link density Macromolecules. 32: 4867-4878. DOI: 10.1021/Ma981945S |
0.333 |
|
1998 |
Kiser PF, Wilson G, Needham D. A synthetic mimic of the secretory granule for drug delivery. Nature. 394: 459-62. PMID 9697768 DOI: 10.1038/28822 |
0.341 |
|
1998 |
Eichenbaum GM, Kiser PF, Simon SA, Needham D. pH and Ion-Triggered Volume Response of Anionic Hydrogel Microspheres. Macromolecules. 31: 5084-93. PMID 9680449 DOI: 10.1021/Ma970897T |
0.33 |
|
Show low-probability matches. |